A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation

被引:63
作者
Keller, Dagmar I.
Huang, Hai
Zhao, Juan
Frank, Rudolf
Suarez, Vivian
Delacretaz, Etienne
Brink, Marijke
Osswald, Stefan
Schwick, Nicola
Chahine, Mohamed
机构
[1] Hop Laval, Quebec Heart Inst, Res Ctr, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Basel Hosp, Cardiobiol Res Grp, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland
[4] Tiefenau Hosp, Dept Cardiol, Bern, Switzerland
[5] Swiss Cardiovasc Ctr, Bern, Switzerland
基金
加拿大健康研究院;
关键词
Brugada syndrome; sudden cardiac death; genetics; SCN5A; sodium channel; Na(v)1.5; fever; ventricular fibrillation;
D O I
10.1016/j.cardiores.2006.02.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Brugada syndrome (BS) is an inherited electrical cardiac disorder characterized by right bundle branch block pattern and ST segment elevation in leads V1 to V3 on surface electrocardiogram that can potentially lead to malignant ventricular tachycardia and sudden cardiac death. About 20% of patients have mutations in the only so far identified gene, SCN5A, which encodes the alpha-subunit of the human cardiac voltage-dependent sodium channel (hNa(v)1.5). Fever has been shown to unmask or trigger the BS phenotype, but the associated molecular and the biophysical mechanisms are still poorly understood. We report on the identification and biophysical characterization of a novel heterozygous missense mutation in SCN5A, F1344S, in a 42-year-old male patient showing the BS phenotype leading to ventricular fibrillation during fever. Methods: The mutation was reproduced in vitro using site-directed mutagenesis and characterized using the patch clamp technique in the whole-cell configuration. Results: The biophysical characterization of the channels carrying the F1344S mutation revealed a 10mV mid-point shift of the G/V curve toward more positive voltages during activation. Raising the temperature to 40.5 degrees C further shifted the mid-point activation by 18mV and significantly changed the slope factor in Na(v)1.5/F1344S mutant channels from -6.49 to -10.27 mV. Conclusions: Our findings indicate for the first time that the shift in activation and change in the slope factor at a higher temperature mimicking fever could reduce sodium currents' amplitude and trigger the manifestation of the BS phenotype. (c) 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:521 / 529
页数:9
相关论文
共 28 条
[21]   Brugada-like electrocardiographic pattern induced by fever [J].
Saura, D ;
García-Alberola, A ;
Carrillo, P ;
Pascual, D ;
Martínez-Sánchez, J ;
Valdés, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2002, 25 (05) :856-859
[22]   A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families [J].
Smits, JPP ;
Koopmann, TT ;
Wilders, R ;
Veldkamp, MW ;
Opthof, T ;
Bhuiyan, ZA ;
Mannens, MMAM ;
Balser, JR ;
Tan, HL ;
Bezzina, CR ;
Wilde, AAM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (06) :969-981
[23]   Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels [J].
Wang, DW ;
George, AL ;
Bennett, PB .
BIOPHYSICAL JOURNAL, 1996, 70 (01) :238-245
[24]   Genomic organization of the human SCN5A gene encoding the cardiac sodium channel [J].
Wang, Q ;
Li, ZZ ;
Shen, JX ;
Keating, MT .
GENOMICS, 1996, 34 (01) :9-16
[25]   Clinical and molecular heterogeneity in the Brugada syndrome - A novel gene locus on chromosome 3 [J].
Weiss, R ;
Barmada, MM ;
Nguyen, T ;
Seibel, JS ;
Cavlovich, D ;
Kornblit, CA ;
Angelilli, A ;
Villanueva, F ;
McNamara, DM ;
London, B .
CIRCULATION, 2002, 105 (06) :707-713
[26]   Proposed diagnostic criteria for the Brugada syndrome [J].
Wilde, AAM ;
Antzelevitch, C ;
Borggrefe, M ;
Brugada, J ;
Brugada, R ;
Brugada, P ;
Corrado, D ;
Hauer, RNW ;
Kass, RS ;
Nademanee, K ;
Priori, SG ;
Towbin, JA .
EUROPEAN HEART JOURNAL, 2002, 23 (21) :1648-1654
[27]   Proposed diagnostic criteria for the Brugada syndrome - Consensus report [J].
Wilde, AAM ;
Antzelevitch, C ;
Borggrefe, M ;
Brugada, J ;
Brugada, R ;
Brugada, P ;
Corrado, D ;
Hauer, RNW ;
Kass, RS ;
Nademanee, K ;
Priori, SG ;
Towbin, JA .
CIRCULATION, 2002, 106 (19) :2514-2519
[28]   Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes [J].
Yang, P ;
Kanki, H ;
Drolet, B ;
Yang, T ;
Wei, J ;
Viswanathan, PC ;
Hohnloser, SH ;
Shimizu, W ;
Schwartz, PJ ;
Stanton, M ;
Murray, KT ;
Norris, K ;
George, AL ;
Roden, DM .
CIRCULATION, 2002, 105 (16) :1943-1948